Intraperitoneal mitomycin C improves survival compared to cytoreductive surgery alone in an experimental model of high-grade pseudomyxoma peritonei
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intraperitoneal mitomycin C improves survival compared to cytoreductive surgery alone in an experimental model of high-grade pseudomyxoma peritonei
Authors
Keywords
Intraperitoneal chemotherapy, Pseudomyxoma peritonei, Mitomycin C, Hyperthermia, Rat model
Journal
CLINICAL & EXPERIMENTAL METASTASIS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-20
DOI
10.1007/s10585-019-09991-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7.
- (2018) François Quenet et al. JOURNAL OF CLINICAL ONCOLOGY
- HIPEC with oxaliplatin for colorectal peritoneal metastasis: The end of the road?
- (2018) Wim Ceelen EJSO
- A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia
- (2016) Norman J. Carr et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1000 patients with perforated appendiceal epithelial tumours
- (2016) N. Ansari et al. EJSO
- Population pharmacokinetics of peritoneal, plasma ultrafiltrated and protein-bound oxaliplatin concentrations in patients with disseminated peritoneal cancer after intraperitoneal hyperthermic chemoperfusion of oxaliplatin following cytoreductive surgery: correlation between oxaliplatin exposure and thrombocytopenia
- (2014) Quentin Chalret du Rieu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Importance of standardizing the dose in hyperthermic intraperitoneal chemotherapy (HIPEC): a pharmacodynamic point of view
- (2013) Maria Isabel Mas-Fuster et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Impact of hyperthermia on pharmacokinetics of intraperitoneal mitomycin C in rats investigated by microdialysis
- (2013) Olaf Sørensen et al. JOURNAL OF SURGICAL ONCOLOGY
- Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in pseudomyxoma peritonei
- (2012) O. Sørensen et al. EJSO
- Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
- (2012) Terence C. Chua et al. JOURNAL OF CLINICAL ONCOLOGY
- Hyperthermia and Intraperitoneal Chemotherapy for the Treatment of Peritoneal Carcinomatosis
- (2011) Yvonne L. B. Klaver et al. ANNALS OF SURGERY
- Validation and use of microdialysis for determination of pharmacokinetic properties of the chemotherapeutic agent mitomycin C - an experimental study
- (2010) Olaf Sørensen et al. BMC CANCER
- Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery for peritoneal carcinomatosis in an experimental model
- (2010) Y. L. B. Klaver et al. BRITISH JOURNAL OF SURGERY
- Epithelial Appendiceal Neoplasms
- (2010) Paul H. Sugarbaker CANCER JOURNAL
- Exploring the peritoneal surface malignancy phenotype—a pilot immunohistochemical study of human pseudomyxoma peritonei and derived animal models
- (2010) Kjersti Flatmark et al. HUMAN PATHOLOGY
- Contribution of HIF-1 and drug penetrance to oxaliplatin resistance in hypoxic colorectal cancer cells
- (2009) D L Roberts et al. BRITISH JOURNAL OF CANCER
- Hyperthermia adds to chemotherapy
- (2008) Rolf D. Issels EUROPEAN JOURNAL OF CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started